{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:26:02Z","timestamp":1792016762201,"version":"4.4.0"},"publisher-location":"Cham","reference-count":130,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319538884","type":"print"},{"value":"9783319538891","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-53889-1_15","type":"book-chapter","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T03:13:29Z","timestamp":1495077209000},"page":"277-299","source":"Crossref","is-referenced-by-count":63,"title":["Epigenetics of Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Silvia","family":"Bassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takshashila","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Monziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Leva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2015.10.060","volume":"625","author":"EA Thomas","year":"2016","unstructured":"Thomas EA. DNA methylation in Huntington\u2019s disease: implications for transgenerational effects. Neurosci Lett. 2016;625:34\u20139.","journal-title":"Neurosci Lett"},{"issue":"4470","key":"15_CR6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.6254144","volume":"210","author":"A Razin","year":"1980","unstructured":"Razin A, Riggs AD. DNA methylation and gene function. Science. 1980;210(4470):604\u201310.","journal-title":"Science"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13072-015-0016-6","volume":"8","author":"A Breiling","year":"2015","unstructured":"Breiling A, Lyko F. Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenetics Chromatin. 2015;8:24.","journal-title":"Epigenetics Chromatin"},{"issue":"6067","key":"15_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/321209a0","volume":"321","author":"AP Bird","year":"1986","unstructured":"Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321(6067):209\u201313.","journal-title":"Nature"},{"issue":"4","key":"15_CR9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s13311-013-0206-5","volume":"10","author":"J Lee","year":"2013","unstructured":"Lee J, et al. Epigenetic mechanisms of neurodegeneration in Huntington\u2019s disease. Neurotherapeutics. 2013;10(4):664\u201376.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"15_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247\u201357.","journal-title":"Cell"},{"issue":"6","key":"15_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ng.830","volume":"43","author":"CJ Klein","year":"2011","unstructured":"Klein CJ, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet. 2011;43(6):595\u2013600.","journal-title":"Nat Genet"},{"issue":"10","key":"15_CR12","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/dds035","volume":"21","author":"J Winkelmann","year":"2012","unstructured":"Winkelmann J, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet. 2012;21(10):2205\u201310.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"15_CR13","first-page":"607","volume":"11","author":"SC Wu","year":"2010","unstructured":"Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol. 2010;11(9):607\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6047","key":"15_CR14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","volume":"333","author":"YF He","year":"2011","unstructured":"He YF, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333(6047):1303\u20137.","journal-title":"Science"},{"issue":"41","key":"15_CR15","doi-asserted-by":"crossref","first-page":"35334","DOI":"10.1074\/jbc.C111.284620","volume":"286","author":"A Maiti","year":"2011","unstructured":"Maiti A, Drohat AC. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J Biol Chem. 2011;286(41):35334\u20138.","journal-title":"J Biol Chem"},{"issue":"10","key":"15_CR16","first-page":"3967","volume":"41","author":"DC Herron","year":"1981","unstructured":"Herron DC, Shank RC. In vivo kinetics of O6-methylguanine and 7-methylguanine formation and persistence in DNA of rats treated with symmetrical dimethylhydrazine. Cancer Res. 1981;41(10):3967\u201372.","journal-title":"Cancer Res"},{"issue":"22","key":"15_CR17","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1073\/pnas.2131819100","volume":"100","author":"S Watanabe","year":"2003","unstructured":"Watanabe S, et al. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc Natl Acad Sci U S A. 2003;100(22):12859\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"15_CR18","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1101\/gad.2.9.1136","volume":"2","author":"F Watt","year":"1988","unstructured":"Watt F, Molloy PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 1988;2(9):1136\u201343.","journal-title":"Genes Dev"},{"issue":"5","key":"15_CR19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","volume":"99","author":"AP Bird","year":"1999","unstructured":"Bird AP, Wolffe AP. Methylation-induced repression\u2014belts, braces, and chromatin. Cell. 1999;99(5):451\u20134.","journal-title":"Cell"},{"issue":"11","key":"15_CR4","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC. Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci. 2008;27(11):2803\u201320.","journal-title":"Eur J Neurosci"},{"issue":"6","key":"15_CR20","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","volume":"110","author":"CW Ng","year":"2013","unstructured":"Ng CW, et al. Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci U S A. 2013;110(6):2354\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR2","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72(6):971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"issue":"19","key":"15_CR21","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet. 2000;9(19):2799\u2013809.","journal-title":"Hum Mol Genet"},{"key":"15_CR3","first-page":"509","volume":"9","author":"E Kerschbamer","year":"2015","unstructured":"Kerschbamer E, Biagioli M. Huntington\u2019s disease as neurodevelopmental disorder: altered chromatin regulation, coding, and non-coding RNA transcription. Front Neurosci. 2015;9:509.","journal-title":"Front Neurosci"},{"issue":"1","key":"15_CR22","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1073\/pnas.1415195112","volume":"112","author":"H Jia","year":"2015","unstructured":"Jia H, et al. HDAC inhibition imparts beneficial transgenerational effects in Huntington\u2019s disease mice via altered DNA and histone methylation. Proc Natl Acad Sci U S A. 2015;112(1):E56\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7347","key":"15_CR23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10102","volume":"473","author":"WA Pastor","year":"2011","unstructured":"Pastor WA, et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature. 2011;473(7347):394\u20137.","journal-title":"Nature"},{"issue":"5929","key":"15_CR24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani M, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930\u20135.","journal-title":"Science"},{"issue":"5929","key":"15_CR25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1169786","volume":"324","author":"S Kriaucionis","year":"2009","unstructured":"Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009;324(5929):929\u201330.","journal-title":"Science"},{"issue":"18","key":"15_CR26","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddt214","volume":"22","author":"FL Wang","year":"2013","unstructured":"Wang FL, et al. Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntingtons disease. Hum Mol Genet. 2013;22(18):3641\u201353.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"15_CR27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/nn.2959","volume":"14","author":"KE Szulwach","year":"2011","unstructured":"Szulwach KE, et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci. 2011;14(12):1607\u201316.","journal-title":"Nat Neurosci"},{"issue":"13","key":"15_CR28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003;12(13):1555\u201367.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"15_CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001;53(4):527\u201352.","journal-title":"Pharmacol Rev"},{"issue":"1386","key":"15_CR1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1098\/rstb.1999.0446","volume":"354","author":"PS Harper","year":"1999","unstructured":"Harper PS. Huntington\u2019s disease: a clinical, genetic and molecular model for polyglutamine repeat disorders. Philos Trans R Soc Lond Ser B Biol Sci. 1999;354(1386):957\u201361.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"15","key":"15_CR30","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, et al. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A. 1988;85(15):5733\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"15_CR31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","volume":"18","author":"C Zuccato","year":"2008","unstructured":"Zuccato C, et al. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease. Brain Pathol. 2008;18(2):225\u201338.","journal-title":"Brain Pathol"},{"issue":"16","key":"15_CR32","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","volume":"18","author":"MC Chiang","year":"2009","unstructured":"Chiang MC, et al. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington\u2019s disease by enhancing the activity of the ubiquitin-proteasome system. Hum Mol Genet. 2009;18(16):2929\u201342.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"15_CR33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10048-010-0248-3","volume":"11","author":"E Taherzadeh-Fard","year":"2010","unstructured":"Taherzadeh-Fard E, et al. Age at onset in Huntington\u2019s disease: replication study on the associations of ADORA2A, HAP1 and OGG1. Neurogenetics. 2010;11(4):435\u20139.","journal-title":"Neurogenetics"},{"key":"15_CR34","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1100\/tsw.2010.164","volume":"10","author":"MT Tebano","year":"2010","unstructured":"Tebano MT, et al. Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington\u2019s disease. Sci World J. 2010;10:1768\u201382.","journal-title":"Sci World J"},{"issue":"3","key":"15_CR35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87(3):493\u2013506.","journal-title":"Cell"},{"issue":"2","key":"15_CR36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","volume":"15","author":"I Villar-Menendez","year":"2013","unstructured":"Villar-Menendez I, et al. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington\u2019s disease. Neruomol Med. 2013;15(2):295\u2013309.","journal-title":"Neruomol Med"},{"issue":"5","key":"15_CR37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00401-013-1103-z","volume":"125","author":"J Lee","year":"2013","unstructured":"Lee J, et al. Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington\u2019s disease. Acta Neuropathol. 2013;125(5):727\u201339.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"15_CR38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2013.01.035","volume":"436","author":"B Thomas","year":"2013","unstructured":"Thomas B, et al. A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease. Anal Biochem. 2013;436(2):112\u201320.","journal-title":"Anal Biochem"},{"issue":"4","key":"15_CR39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.bjc.6601575","volume":"90","author":"SB Hake","year":"2004","unstructured":"Hake SB, Xiao A, Allis CD. Linking the epigenetic \u2018language\u2019 of covalent histone modifications to cancer. Br J Cancer. 2004;90(4):761\u20139.","journal-title":"Br J Cancer"},{"issue":"2","key":"15_CR40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2010-100303","volume":"21","author":"SC Marques","year":"2010","unstructured":"Marques SC, et al. Alzheimer\u2019s disease: the quest to understand complexity. J Alzheimers Dis. 2010;21(2):373\u201383.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"15_CR41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","volume":"90","author":"L Chouliaras","year":"2010","unstructured":"Chouliaras L, et al. Epigenetic regulation in the pathophysiology of Alzheimer\u2019s disease. Prog Neurobiol. 2010;90(4):498\u2013510.","journal-title":"Prog Neurobiol"},{"issue":"5532","key":"15_CR42","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074\u201380.","journal-title":"Science"},{"issue":"6","key":"15_CR43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","volume":"2","author":"G Sadri-Vakili","year":"2006","unstructured":"Sadri-Vakili G, Cha JH. Mechanisms of disease: histone modifications in Huntington\u2019s disease. Nat Clin Pract Neurol. 2006;2(6):330\u20138.","journal-title":"Nat Clin Pract Neurol"},{"issue":"6","key":"15_CR44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","volume":"9","author":"MM Suzuki","year":"2008","unstructured":"Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008;9(6):465\u201376.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"15_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-140134","volume":"4","author":"KE Glajch","year":"2015","unstructured":"Glajch KE, Sadri-Vakili G. Epigenetic mechanisms involved in Huntington\u2019s disease pathogenesis. J Huntingtons Dis. 2015;4(1):1\u201315.","journal-title":"J Huntingtons Dis"},{"issue":"4","key":"15_CR46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrm3931","volume":"16","author":"E Verdin","year":"2015","unstructured":"Verdin E, Ott M. 50 Years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol. 2015;16(4):258\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"25","key":"15_CR47","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","volume":"33","author":"LM Valor","year":"2013","unstructured":"Valor LM, et al. Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. J Neurosci. 2013;33(25):10471\u201382.","journal-title":"J Neurosci"},{"issue":"7","key":"15_CR48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.bcp.2004.05.010","volume":"68","author":"AJ Ruijter de","year":"2004","unstructured":"de Ruijter AJ, et al. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. Biochem Pharmacol. 2004;68(7):1279\u201388.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"15_CR49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","volume":"17","author":"P Gallinari","year":"2007","unstructured":"Gallinari P, et al. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 2007;17(3):195\u2013211.","journal-title":"Cell Res"},{"issue":"4","key":"15_CR50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","volume":"13","author":"R Saha","year":"2006","unstructured":"Saha R, Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 2006;13(4):539\u201350.","journal-title":"Cell Death Differ"},{"issue":"9","key":"15_CR51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","volume":"23","author":"JH Cha","year":"2000","unstructured":"Cha JH. Transcriptional dysregulation in Huntington\u2019s disease. Trends Neurosci. 2000;23(9):387\u201392.","journal-title":"Trends Neurosci"},{"issue":"5","key":"15_CR52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC. Transcriptional abnormalities in Huntington disease. Trends Genet. 2003;19(5):233\u20138.","journal-title":"Trends Genet"},{"issue":"1","key":"15_CR53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1471-4159.2003.01991.x","volume":"87","author":"M Hoshino","year":"2003","unstructured":"Hoshino M, et al. Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein. J Neurochem. 2003;87(1):257\u201367.","journal-title":"J Neurochem"},{"issue":"1","key":"15_CR54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, et al. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003;35(1):76\u201383.","journal-title":"Nat Genet"},{"issue":"12","key":"15_CR55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci. 2005;6(12):919\u201330.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"15_CR56","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","volume":"100","author":"H Ryu","year":"2003","unstructured":"Ryu H, et al. Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci. 2003;100(7):4281\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"26","key":"15_CR57","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","volume":"98","author":"A McCampbell","year":"2001","unstructured":"McCampbell A, et al. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci. 2001;98(26):15179\u201384.","journal-title":"Proc Natl Acad Sci"},{"issue":"6857","key":"15_CR58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 2001;413(6857):739\u201343.","journal-title":"Nature"},{"key":"15_CR59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","volume":"8","author":"C Simoes-Pires","year":"2013","unstructured":"Simoes-Pires C, et al. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol Neurodegener. 2013;8:7.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"15_CR60","doi-asserted-by":"crossref","first-page":"e1001717","DOI":"10.1371\/journal.pbio.1001717","volume":"11","author":"M Mielcarek","year":"2013","unstructured":"Mielcarek M, et al. HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol. 2013;11(11):e1001717.","journal-title":"PLoS Biol"},{"issue":"23","key":"15_CR61","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","volume":"17","author":"J Pallos","year":"2008","unstructured":"Pallos J, et al. Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease. Hum Mol Genet. 2008;17(23):3767\u201375.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"15_CR62","doi-asserted-by":"crossref","first-page":"e5747","DOI":"10.1371\/journal.pone.0005747","volume":"4","author":"CL Benn","year":"2009","unstructured":"Benn CL, et al. Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6\/2 mouse model of Huntington\u2019s disease. PLoS One. 2009;4(6):e5747.","journal-title":"PLoS One"},{"key":"15_CR63","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/srep01311","volume":"3","author":"S Dhar","year":"2013","unstructured":"Dhar S, et al. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs. Sci Rep. 2013;3:1311.","journal-title":"Sci Rep"},{"issue":"5531","key":"15_CR64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1060781","volume":"293","author":"H Wang","year":"2001","unstructured":"Wang H, et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science. 2001;293(5531):853\u20137.","journal-title":"Science"},{"issue":"24","key":"15_CR65","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0960-9822(02)01387-8","volume":"12","author":"S Daujat","year":"2002","unstructured":"Daujat S, et al. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr Biol. 2002;12(24):2090\u20137.","journal-title":"Curr Biol"},{"issue":"21","key":"15_CR66","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1128\/MCB.24.21.9630-9645.2004","volume":"24","author":"S Pal","year":"2004","unstructured":"Pal S, et al. Human SWI\/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol. 2004;24(21):9630\u201345.","journal-title":"Mol Cell Biol"},{"issue":"11","key":"15_CR67","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1080\/15384101.2015.1033595","volume":"14","author":"T Ratovitski","year":"2015","unstructured":"Ratovitski T, et al. PRMT5-mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington\u2019s disease (HD). Cell Cycle. 2015;14(11):1716\u201329.","journal-title":"Cell Cycle"},{"issue":"7","key":"15_CR68","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi Y, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119(7):941\u201353.","journal-title":"Cell"},{"issue":"40","key":"15_CR69","doi-asserted-by":"crossref","first-page":"14738","DOI":"10.1073\/pnas.0604005103","volume":"103","author":"LM Hoffart","year":"2006","unstructured":"Hoffart LM, et al. Direct spectroscopic detection of a C-H-cleaving high-spin Fe(IV) complex in a prolyl-4-hydroxylase. Proc Natl Acad Sci U S A. 2006;103(40):14738\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"15_CR70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nchembio863","volume":"3","author":"A Ozer","year":"2007","unstructured":"Ozer A, Bruick RK. Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol. 2007;3(3):144\u201353.","journal-title":"Nat Chem Biol"},{"issue":"12","key":"15_CR71","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrm3230","volume":"12","author":"B Schuettengruber","year":"2011","unstructured":"Schuettengruber B, et al. Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol. 2011;12(12):799\u2013814.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7010","key":"15_CR72","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature02985","volume":"431","author":"H Wang","year":"2004","unstructured":"Wang H, et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature. 2004;431(7010):873\u20138.","journal-title":"Nature"},{"issue":"6","key":"15_CR73","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","volume":"20","author":"R Cao","year":"2005","unstructured":"Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell. 2005;20(6):845\u201354.","journal-title":"Mol Cell"},{"issue":"3","key":"15_CR74","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.molcel.2012.01.002","volume":"45","author":"Z Gao","year":"2012","unstructured":"Gao Z, et al. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell. 2012;45(3):344\u201356.","journal-title":"Mol Cell"},{"issue":"4","key":"15_CR75","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cell.2011.12.029","volume":"148","author":"L Tavares","year":"2012","unstructured":"Tavares L, et al. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell. 2012;148(4):664\u201378.","journal-title":"Cell"},{"issue":"1","key":"15_CR76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.celrep.2012.11.026","volume":"3","author":"L Morey","year":"2013","unstructured":"Morey L, et al. RYBP and Cbx7 define specific biological functions of polycomb complexes in mouse embryonic stem cells. Cell Rep. 2013;3(1):60\u20139.","journal-title":"Cell Rep"},{"issue":"11","key":"15_CR77","doi-asserted-by":"crossref","first-page":"e1500737","DOI":"10.1126\/sciadv.1500737","volume":"1","author":"S Aranda","year":"2015","unstructured":"Aranda S, Mas G, Di Croce L. Regulation of gene transcription by Polycomb proteins. Sci Adv. 2015;1(11):e1500737.","journal-title":"Sci Adv"},{"issue":"1","key":"15_CR78","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1093\/nar\/gks941","volume":"41","author":"AH Smits","year":"2013","unstructured":"Smits AH, et al. Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics. Nucleic Acids Res. 2013;41(1):e28.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"15_CR79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","volume":"32","author":"R Margueron","year":"2008","unstructured":"Margueron R, et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell. 2008;32(4):503\u201318.","journal-title":"Mol Cell"},{"issue":"2","key":"15_CR80","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","volume":"125","author":"BE Bernstein","year":"2006","unstructured":"Bernstein BE, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315\u201326.","journal-title":"Cell"},{"issue":"7153","key":"15_CR81","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature06008","volume":"448","author":"TS Mikkelsen","year":"2007","unstructured":"Mikkelsen TS, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007;448(7153):553\u201360.","journal-title":"Nature"},{"issue":"1","key":"15_CR82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cell.2012.09.002","volume":"151","author":"P Voigt","year":"2012","unstructured":"Voigt P, et al. Asymmetrically modified nucleosomes. Cell. 2012;151(1):181\u201393.","journal-title":"Cell"},{"issue":"4","key":"15_CR83","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/hmg\/ddp524","volume":"19","author":"IS Seong","year":"2010","unstructured":"Seong IS, et al. Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet. 2010;19(4):573\u201383.","journal-title":"Hum Mol Genet"},{"issue":"32","key":"15_CR84","doi-asserted-by":"crossref","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","volume":"110","author":"M Vashishtha","year":"2013","unstructured":"Vashishtha M, et al. Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci U S A. 2013;110(32):E3027\u201336.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"15_CR85","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/hmg\/ddv006","volume":"24","author":"M Biagioli","year":"2015","unstructured":"Biagioli M, et al. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum Mol Genet. 2015;24(9):2442\u201357.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"15_CR86","doi-asserted-by":"crossref","first-page":"e0144398","DOI":"10.1371\/journal.pone.0144398","volume":"10","author":"X Dong","year":"2015","unstructured":"Dong X, et al. The role of H3K4me3 in transcriptional regulation is altered in Huntington\u2019s disease. PLoS One. 2015;10(12):e0144398.","journal-title":"PLoS One"},{"issue":"2","key":"15_CR87","doi-asserted-by":"crossref","first-page":"e1004188","DOI":"10.1371\/journal.pgen.1004188","volume":"10","author":"AG Hoss","year":"2014","unstructured":"Hoss AG, et al. MicroRNAs located in the Hox gene clusters are implicated in Huntington\u2019s disease pathogenesis. PLoS Genet. 2014;10(2):e1004188.","journal-title":"PLoS Genet"},{"issue":"12","key":"15_CR88","doi-asserted-by":"crossref","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf A, et al. RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS One. 2015;10(12):e0143563.","journal-title":"PLoS One"},{"issue":"10","key":"15_CR89","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nn.4360","volume":"19","author":"M Schimmelmann von","year":"2016","unstructured":"von Schimmelmann M, et al. Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat Neurosci. 2016;19(10):1321\u201330.","journal-title":"Nat Neurosci"},{"issue":"10","key":"15_CR90","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.470008","volume":"22","author":"D Pasini","year":"2008","unstructured":"Pasini D, et al. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev. 2008;22(10):1345\u201355.","journal-title":"Genes Dev"},{"issue":"5529","key":"15_CR91","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science. 2001;293(5529):493\u20138.","journal-title":"Science"},{"issue":"5\u20136","key":"15_CR92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E. Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol. 2007;81(5\u20136):294\u2013330.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"15_CR93","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/hmg\/ddu561","volume":"24","author":"G Bai","year":"2015","unstructured":"Bai G, et al. Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains. Hum Mol Genet. 2015;24(5):1441\u201356.","journal-title":"Hum Mol Genet"},{"issue":"50","key":"15_CR94","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, et al. ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci U S A. 2006;103(50):19176\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6610","key":"15_CR95","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/384641a0","volume":"384","author":"AJ Bannister","year":"1996","unstructured":"Bannister AJ, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 1996;384(6610):641\u20133.","journal-title":"Nature"},{"issue":"9","key":"15_CR96","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/hmg\/7.9.1463","volume":"7","author":"PW Faber","year":"1998","unstructured":"Faber PW, et al. Huntingtin interacts with a family of WW domain proteins. Hum Mol Genet. 1998;7(9):1463\u201374.","journal-title":"Hum Mol Genet"},{"issue":"14","key":"15_CR97","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/9.14.2175","volume":"9","author":"LA Passani","year":"2000","unstructured":"Passani LA, et al. Huntingtin\u2019s WW domain partners in Huntington\u2019s disease post mortem brain fulfill genetic criteria for direct involvement in Huntington\u2019s disease pathogenesis. Hum Mol Genet. 2000;9(14):2175\u201382.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"15_CR98","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.str.2013.12.005","volume":"22","author":"YG Gao","year":"2014","unstructured":"Gao YG, et al. Autoinhibitory structure of the WW domain of HYPB\/SETD2 regulates its interaction with the proline-rich region of huntingtin. Structure. 2014;22(3):378\u201386.","journal-title":"Structure"},{"issue":"7","key":"15_CR99","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1073\/pnas.0915033107","volume":"107","author":"M Hu","year":"2010","unstructured":"Hu M, et al. Histone H3 lysine 36 methyltransferase Hypb\/Setd2 is required for embryonic vascular remodeling. Proc Natl Acad Sci U S A. 2010;107(7):2956\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"15_CR100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cell.2010.11.056","volume":"144","author":"RF Luco","year":"2011","unstructured":"Luco RF, et al. Epigenetics in alternative pre-mRNA splicing. Cell. 2011;144(1):16\u201326.","journal-title":"Cell"},{"issue":"3","key":"15_CR101","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/bies.20544","volume":"29","author":"RJ Taft","year":"2007","unstructured":"Taft RJ, Pheasant M, Mattick JS. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays. 2007;29(3):288\u201399.","journal-title":"Bioessays"},{"issue":"5","key":"15_CR102","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1073858408319187","volume":"14","author":"TR Mercer","year":"2008","unstructured":"Mercer TR, et al. Noncoding RNAs in long-term memory formation. Neuroscientist. 2008;14(5):434\u201345.","journal-title":"Neuroscientist"},{"issue":"3","key":"15_CR103","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12031-012-9880-8","volume":"49","author":"MN Ziats","year":"2013","unstructured":"Ziats MN, Rennert OM. Aberrant expression of long noncoding RNAs in autistic brain. J Mol Neurosci. 2013;49(3):589\u201393.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"15_CR104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00439-013-1356-6","volume":"133","author":"C Pastori","year":"2014","unstructured":"Pastori C, et al. Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in fragile X syndrome and fragile X-associated tremor\/ataxia syndrome. Hum Genet. 2014;133(1):59\u201367.","journal-title":"Hum Genet"},{"issue":"11","key":"15_CR105","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11033-016-4054-3","volume":"43","author":"M Majidinia","year":"2016","unstructured":"Majidinia M, et al. The roles of non-coding RNAs in Parkinson\u2019s disease. Mol Biol Rep. 2016;43(11):1193\u2013204.","journal-title":"Mol Biol Rep"},{"issue":"44","key":"15_CR106","doi-asserted-by":"crossref","first-page":"71087","DOI":"10.18632\/oncotarget.12122","volume":"7","author":"J Hu","year":"2016","unstructured":"Hu J, et al. Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosis. Oncotarget. 2016;7(44):71087\u201398.","journal-title":"Oncotarget"},{"issue":"23","key":"15_CR107","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1073\/pnas.0903103106","volume":"106","author":"LA Hindorff","year":"2009","unstructured":"Hindorff LA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106(23):9362\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"15_CR108","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"1","key":"15_CR109","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/jhg.2016.91","volume":"62","author":"M Molasy","year":"2017","unstructured":"Molasy M, et al. MicroRNAs in glaucoma and neurodegenerative diseases. J Hum Genet. 2017;62(1):105\u201312.","journal-title":"J Hum Genet"},{"issue":"1","key":"15_CR110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","volume":"227","author":"ST Lee","year":"2011","unstructured":"Lee ST, et al. Altered microRNA regulation in Huntington\u2019s disease models. Exp Neurol. 2011;227(1):172\u20139.","journal-title":"Exp Neurol"},{"issue":"53","key":"15_CR111","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, et al. The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci. 2008;28(53):14341\u20136.","journal-title":"J Neurosci"},{"issue":"3","key":"15_CR112","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","volume":"11","author":"R Johnson","year":"2009","unstructured":"Johnson R, Buckley NJ. Gene dysregulation in Huntington\u2019s disease: REST, microRNAs and beyond. Neruomol Med. 2009;11(3):183\u201399.","journal-title":"Neruomol Med"},{"issue":"9","key":"15_CR113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrm3854","volume":"15","author":"A Shenoy","year":"2014","unstructured":"Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 2014;15(9):565\u201376.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"15_CR114","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jnc.12090","volume":"124","author":"C Soldati","year":"2013","unstructured":"Soldati C, et al. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington\u2019s disease. J Neurochem. 2013;124(3):418\u201330.","journal-title":"J Neurochem"},{"issue":"17","key":"15_CR115","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1093\/hmg\/ddr263","volume":"20","author":"DW Chung","year":"2011","unstructured":"Chung DW, et al. A natural antisense transcript at the Huntington\u2019s disease repeat locus regulates HTT expression. Hum Mol Genet. 2011;20(17):3467\u201377.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"15_CR116","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet. 2006;15(6):965\u201377.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"15_CR117","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nbd.2011.12.006","volume":"46","author":"R Johnson","year":"2012","unstructured":"Johnson R. Long non-coding RNAs in Huntington\u2019s disease neurodegeneration. Neurobiol Dis. 2012;46(2):245\u201354.","journal-title":"Neurobiol Dis"},{"issue":"28","key":"15_CR118","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.0904715106","volume":"106","author":"AM Khalil","year":"2009","unstructured":"Khalil AM, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106(28):11667\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"15_CR119","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2443.2000.00320.x","volume":"5","author":"N Miyoshi","year":"2000","unstructured":"Miyoshi N, et al. Identification of an imprinted gene, Meg3\/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5(3):211\u201320.","journal-title":"Genes Cells"},{"key":"15_CR120","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1038\/ncomms8743","volume":"6","author":"T Mondal","year":"2015","unstructured":"Mondal T, et al. MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures. Nat Commun. 2015;6:7743.","journal-title":"Nat Commun"},{"issue":"3","key":"15_CR121","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1101\/gr.087775.108","volume":"19","author":"H Sunwoo","year":"2009","unstructured":"Sunwoo H, et al. MEN epsilon\/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res. 2009;19(3):347\u201359.","journal-title":"Genome Res"},{"key":"15_CR1000","doi-asserted-by":"crossref","unstructured":"Francelle et al. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiology of Aging, 2014;36(3):1601.e7\u20131601.e16.","DOI":"10.1016\/j.neurobiolaging.2014.11.014"},{"issue":"26","key":"15_CR122","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","volume":"98","author":"A McCampbell","year":"2001","unstructured":"McCampbell A, et al. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci U S A. 2001;98(26):15179\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"15_CR123","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/mds.21632","volume":"22","author":"P Hogarth","year":"2007","unstructured":"Hogarth P, Lovrecic L, Krainc D. Sodium phenylbutyrate in Huntington\u2019s disease: a dose-finding study. Mov Disord. 2007;22(13):1962\u20134.","journal-title":"Mov Disord"},{"issue":"17","key":"15_CR124","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1093\/nar\/gkt590","volume":"41","author":"JP Lopez-Atalaya","year":"2013","unstructured":"Lopez-Atalaya JP, et al. Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition. Nucleic Acids Res. 2013;41(17):8072\u201384.","journal-title":"Nucleic Acids Res"},{"issue":"5942","key":"15_CR125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325(5942):834\u201340.","journal-title":"Science"},{"issue":"7427","key":"15_CR126","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","volume":"492","author":"MT McCabe","year":"2012","unstructured":"McCabe MT, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. 2012;492(7427):108\u201312.","journal-title":"Nature"},{"issue":"1","key":"15_CR127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-016-0225-2","volume":"8","author":"H Wapenaar","year":"2016","unstructured":"Wapenaar H, Dekker FJ. Histone acetyltransferases: challenges in targeting bi-substrate enzymes. Clin Epigenetics. 2016;8(1):1.","journal-title":"Clin Epigenetics"},{"key":"15_CR128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","volume":"983","author":"S Thiagalingam","year":"2003","unstructured":"Thiagalingam S, et al. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci. 2003;983:84\u2013100.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"15_CR129","first-page":"7","volume":"10","author":"E Mortaz","year":"2011","unstructured":"Mortaz E, et al. Epigenetics and chromatin remodeling play a role in lung disease. Tanaffos. 2011;10(4):7\u201316.","journal-title":"Tanaffos"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroepigenomics in Aging and Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-53889-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:49:32Z","timestamp":1750254572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-53889-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319538884","9783319538891"],"references-count":130,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-53889-1_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}